Business & Finance
Dyax Corp. reports net loss of $7.9 million for second quarter
Published in Drug Week, August 25th, 2006
For the quarter ended June 30, 2006, the company reported a net loss of $8.7 million or $0.20 per share, as compared to a net loss of $7.9 million or $0.23 per share for the comparable quarter in 2005. For the six months ended June 30, 2006, Dyax reported a net loss of $18.7 million or $0.45 per share, as compared to a net loss of $16.4 million or $0.50 per share for the comparable six month period in 2005.
On January 1, 2006, the company adopted Statement of Financial Accounting Standards No. 123 (revised 2004), "Accounting for Stock-Based Compensation". For...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-08-25)
More Articles from Drug Week
- Addiction Medicine
Dopamine D3 receptor antagonist blocks cocaine reward effects - Allergy & Immunology
CC chemokine receptor antagonists selectively inhibit eosinophil influx into lungs - Cell Regulation
Helenalin plays important role in Akt signaling and Skp2 expression in 3T3-L1 preadipocytes - Cystic Fibrosis
Inspire initiates phase III trial of denufosol tetrasodium in cystic fibrosis patients - DNA Vaccine
Plasmid size up to 20 kbp does not limit lung gene transfer using DNA nanoparticles - Abdominal Infections
Study finds once-daily Avelox effective as multidose antibiotic in treating abdominal infections - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
